Abstract:Background Heterogeneity is a common finding within tumours. We evaluated the imaging features of tumours based on the decomposition of tumoural dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) data to identify their prognostic value for breast cancer survival and to explore their biological importance. Methods Imaging features ( n = 14), such as texture, histogram distribution and morphological features, were extracted to determine their associations with recurrence-free survival (RFS) in patients in the training cohort ( n = 61) from The Cancer Imaging Archive (TCIA). The prognostic value of the features was evaluated in an independent dataset of 173 patients (i.e. the reproducibility cohort) from the TCIA I-SPY 1 TRIAL dataset. Radiogenomic analysis was performed in an additional cohort, the radiogenomic cohort ( n = 87), using DCE-MRI from TCGA-BRCA and corresponding gene expression data from The Cancer Genome Atlas (TCGA). The MRI tumour area was decomposed by convex analysis of mixtures (CAM), resulting in 3 components that represent plasma input, fast-flow kinetics and slow-flow kinetics. The prognostic MRI features were associated with the gene expression module in which the pathway was analysed. Furthermore, a multigene signature for each prognostic imaging feature was built, and the prognostic value for RFS and overall survival (OS) was confirmed in an additional cohort from TCGA. Results Three image features (i.e. the maximum probability from the precontrast MR series, the median value from the second postcontrast series and the overall tumour volume) were independently correlated with RFS ( p values of 0.0018, 0.0036 and 0.0032, respectively). The maximum probability feature from the fast-flow kinetics subregion was also significantly associated with RFS and OS in the reproducibility cohort. Additionally, this feature had a high correlation with the gene expression module ( r = 0.59), and the pathway analysis showed that Ras signalling, a breast cancer-related pathway, was significantly enriched (corrected p value = 0.0044). Gene signatures ( n = 43) associated with the maximum probability feature were assessed for associations with RFS ( p = 0.035) and OS ( p = 0.027) in an independent dataset containing 1010 gene expression samples. Among the 43 gene signatures, Ras signalling was also significantly enriched. Conclusions Dynamic pattern deconvolution revealed that tumour heterogeneity was associated with poor survival and cancer-related pathways in breast cancer.

DCE-MRI Based Analysis of Intratumor Heterogeneity by Decomposing Method for Prediction of HER2 Status in Breast Cancer.

Intratumor Heterogeneity of DCE-MRI Reveals Ki-67 Proliferation Status in Breast Cancer

Analysis of DCE-MRI features in tumor and the surrounding stroma for prediction of Ki-67 proliferation status in breast cancer

Heterogeneity Of Tumor And Its Surrounding Stroma On Dce-Mri And Diffusion Weighted Imaging In Predicting Histological Grade And Lymph Node Status Of Breast Cancer

DCE-MRI Texture Analysis with Tumor Subregion Partitioning for Predicting Ki-67 Status of Estrogen Receptor-Positive Breast Cancers.

MRI-based machine learning radiomics for prediction of HER2 expression status in breast invasive ductal carcinoma

Radiomic Analysis of Pharmacokinetic Heterogeneity Within Tumor Based on the Unsupervised Decomposition of Dynamic Contrast-Enhanced MRI for Predicting Histological Characteristics of Breast Cancer

Preliminary study on DCE-MRI radiomics analysis for differentiation of HER2-low and HER2-zero breast cancer

A quantitative heterogeneity analysis approach to molecular subtype recognition of breast cancer in dynamic contrast-enhanced magnetic imaging images from radiomics data

Radiomic Analysis of Imaging Heterogeneity in Tumours and the Surrounding Parenchyma Based on Unsupervised Decomposition of DCE-MRI for Predicting Molecular Subtypes of Breast Cancer.

Tumour Heterogeneity Revealed by Unsupervised Decomposition of Dynamic Contrast-Enhanced Magnetic Resonance Imaging is Associated with Underlying Gene Expression Patterns and Poor Survival in Breast Cancer Patients

Radiomic Analysis Reveals DCE-MRI Features for Prediction of Molecular Subtypes of Breast Cancer.

Analysis of DCE-MRI Features in Tumor for Prediction of the Prognosis in Breast Cancer

Unsupervised Analysis Based on DCE-MRI Radiomics Features Revealed Three Novel Breast Cancer Subtypes with Distinct Clinical Outcomes and Biological Characteristics

Performance of a semi-automatic machine leaning method for discriminating HER2 2+ status of breast cancers based on DCE-MRI (Preprint)

The Potential Use of DCE-MRI Texture Analysis to Predict HER2 2+ Status.

Identifying Associations Between DCE-MRI Radiomic Features and Expression Heterogeneity of Hallmark Pathways in Breast Cancer: A Multi-Center Radiogenomic Study.

Assessing the Role of Different Heterogeneous Regions in DCE-MRI for Predicting Molecular Subtypes of Breast Cancer Based on Network Architecture Search and Vision Transformer

Comparison of Dynamic Contrast‐Enhanced MRI and Non‐Mono‐Exponential Model‐Based Diffusion‐Weighted Imaging for the Prediction of Prognostic Biomarkers and Molecular Subtypes of Breast Cancer Based on Radiomics

Use of MRI Radiomics Models in Evaluating the Low HER2 Expression in Breast Cancer